share_log

港股CXO板块集体走强:昭衍新药涨近7%,金斯瑞涨超5%

Gelonghui Finance ·  May 5 22:30
格隆汇5月6日|港股医药股整体上涨,其中,创新药、CXO方向表现最为突出。CXO个股方面,昭衍新药、康龙化成、药明生物和泰格医药涨超6%,金斯瑞涨超5%,凯莱英涨近5%,药明康德涨超3%。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment